Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
usx:srne usx:regn usx:lly Blog PostThese Nasdaq Biotech Stocks Doubled in 2020. Here's Why They're Soaring on Friday
usx:srne usx:bngo Blog PostWhy Co-Diagnostics, Ocugen, and Sorrento Stocks Are Sinking This Week
usx:srne usx:codx usx:ocgn Blog PostHow Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?
usx:mrna usx:pfe usx:bntx usx:srne Blog PostSorrento Therapeutics' CEO Henry Ji on the Status of the Company's 3 COVID-19 Tests
usx:srne Blog PostSorrento Therapeutics on COVID-19 Therapy Competition: "Our Antibody Is Better Than Theirs"
usx:srne usx:regn usx:lly Blog PostWhy Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped Today
usx:srne usx:regn usx:agen usx:adap usx:cmpi Blog Post